Beyond Air (XAIR) Cash from Investing Activities Growth (3y) (2019 - 2026)
Powered by 
Analysis
Beyond Air (XAIR) Cash from Investing Activities Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 17.83% |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | -26.99% |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | -44.28% |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | -6.23% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | -32.54% |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | -68.12% |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | 18.69% |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 37.39% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | -17.67% |
| 10 | Beyond Air | 2.25 Mn | -8.67 Mn | 225,000.00 | 26.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.99% |
| Mar 31, 2026 | -27.04% |
| Dec 31, 2025 | -42.95% |
| Sep 30, 2025 | 26.30% |
| Jun 30, 2025 | 61.11% |
| Mar 31, 2025 | 112.63% |
| Dec 31, 2024 | -154.87% |
| Sep 30, 2024 | 197.31% |
| Jun 30, 2024 | 389.56% |
| Mar 31, 2024 | -336.82% |
| Dec 31, 2023 | 101.13% |
| Sep 30, 2023 | -53.64% |
| Jun 30, 2023 | -240.96% |
| Mar 31, 2023 | -10.74% |
| Dec 31, 2022 | 42.50% |
| Sep 30, 2022 | -123.73% |
| Jun 30, 2022 | 66.10% |
| Mar 31, 2022 | 64.01% |
| Dec 31, 2021 | -30.81% |
| Sep 30, 2021 | -33.51% |